HTCC polymers efficiently inhibit entry of SARS-CoV-2, MERS-CoV, HCoV-NL63, etc.
Most proposals involve early use of a nebulized solution in primary pulmonary epithelial viral infections.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889042/ …
https://www.biorxiv.org/content/10.1101/2020.03.29.014183v1 …
From checking notes with @s_r_constantin https://twitter.com/s_r_constantin/status/1250646918201409540 …pic.twitter.com/kvkM95z2Rv